HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 243 filers reported holding HAEMONETICS CORP in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $18,385 | -4.5% | 215 | 0.0% | 0.00% | -50.0% |
Q3 2023 | $19,260 | +5.2% | 215 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $18,305 | -4.2% | 215 | -6.9% | 0.00% | 0.0% |
Q1 2023 | $19,115 | +5.2% | 231 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $18,168 | -17.4% | 231 | -23.3% | 0.00% | -33.3% |
Q3 2022 | $22,000 | +10.0% | 301 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $20,000 | -20.0% | 301 | -23.8% | 0.00% | 0.0% |
Q1 2022 | $25,000 | +19.0% | 395 | 0.0% | 0.00% | +50.0% |
Q4 2021 | $21,000 | -25.0% | 395 | 0.0% | 0.00% | -33.3% |
Q3 2021 | $28,000 | +7.7% | 395 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $26,000 | -49.0% | 395 | -13.2% | 0.00% | -50.0% |
Q1 2021 | $51,000 | -16.4% | 455 | -11.0% | 0.01% | -25.0% |
Q4 2020 | $61,000 | +35.6% | 511 | 0.0% | 0.01% | +33.3% |
Q3 2020 | $45,000 | -31.8% | 511 | -30.5% | 0.01% | -40.0% |
Q2 2020 | $66,000 | -33.3% | 735 | -25.8% | 0.01% | -41.2% |
Q1 2020 | $99,000 | -13.2% | 990 | 0.0% | 0.02% | +6.2% |
Q4 2019 | $114,000 | -10.9% | 990 | -2.7% | 0.02% | -15.8% |
Q3 2019 | $128,000 | -77.8% | 1,017 | -78.8% | 0.02% | -77.6% |
Q2 2019 | $576,000 | +11.6% | 4,789 | -18.8% | 0.08% | +10.4% |
Q1 2019 | $516,000 | -56.7% | 5,899 | -50.4% | 0.08% | -61.5% |
Q4 2018 | $1,191,000 | -12.7% | 11,903 | 0.0% | 0.20% | +4.7% |
Q3 2018 | $1,364,000 | +19.4% | 11,903 | -6.5% | 0.19% | +7.9% |
Q2 2018 | $1,142,000 | 0.0% | 12,736 | -18.4% | 0.18% | -4.3% |
Q1 2018 | $1,142,000 | +9.8% | 15,610 | -12.8% | 0.18% | +14.2% |
Q4 2017 | $1,040,000 | +29.5% | 17,905 | 0.0% | 0.16% | +25.6% |
Q3 2017 | $803,000 | +13.6% | 17,905 | 0.0% | 0.13% | +13.2% |
Q2 2017 | $707,000 | -2.6% | 17,905 | 0.0% | 0.11% | -5.0% |
Q1 2017 | $726,000 | +0.8% | 17,905 | 0.0% | 0.12% | -7.7% |
Q4 2016 | $720,000 | +11.1% | 17,905 | 0.0% | 0.13% | +10.2% |
Q3 2016 | $648,000 | +548.0% | 17,905 | +475.9% | 0.12% | +594.1% |
Q3 2015 | $100,000 | -27.0% | 3,109 | -6.0% | 0.02% | -15.0% |
Q2 2015 | $137,000 | -8.1% | 3,309 | 0.0% | 0.02% | -9.1% |
Q1 2015 | $149,000 | -13.9% | 3,309 | -19.4% | 0.02% | -21.4% |
Q4 2013 | $173,000 | +45.4% | 4,106 | +38.1% | 0.03% | +27.3% |
Q3 2013 | $119,000 | – | 2,974 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |